Article
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses counseling points for OIC patients.
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses counseling points for OIC patients.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria
2 Commerce Drive
Cranbury, NJ 08512